Story perspectives
HPV Vaccine Success Hindered by Access in Developing Nations
2/23/2026
1 of 1
Story summary
- Research shows human papillomavirus causes cervical cancer, the fourth most common cancer in women globally.
- Margaret Stanley noted that human papillomavirus can remain undetected in the body for years, complicating vaccine development.
- The first successful HPV vaccine trials showed significant protection against infections.
- Access to vaccines remains a challenge in low- and middle-income countries because cervical cancer rates are high in India and Kenya.
